RadNet Acquires See-Mode Technologies to Expand Ultrasound AI Portfolio
June 5, 2025
RadNet has acquired ultrasound AI vendor See-Mode Technologies, aiming to enhance workflow efficiency and expand its imaging AI offerings.
Key Details
- RadNet completed the acquisition of See-Mode Technologies, an AI company focused on breast and thyroid ultrasound analysis.
- See-Mode's FDA-cleared thyroid solution is already deployed at some RadNet outpatient centers, showing a 30% reduction in scan times.
- Approximately 20 million ultrasound exams for thyroid and breast are performed annually in the US, highlighting a large addressable market.
- RadNet plans to integrate See-Mode’s products into its DeepHealth AI portfolio and market them to third parties.
- The deal follows earlier acquisitions of iCAD, Quantib, Aidence, and Kheiron by RadNet, further bolstering their AI division.
- Financial terms of the acquisition were not disclosed.
Why It Matters
This acquisition demonstrates RadNet's commitment to expanding AI-driven workflow improvements in high-volume, complex ultrasound exams, potentially increasing access and efficiency. The integration of advanced AI solutions is positioned to benefit both clinicians and patients, with commercial implications for the broader radiology AI market.